LOVE — Cannara Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Cannara Biotech, fiscal year end - August 31st, CAD millions except per share, conversion factor applied.

	2020 August 31st	2021 August 31st	2022 August 31st	2023 August 31st	2024 August 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	7.77	8.16	12.1	4.27	6.62
Net Total Accounts Receivable
Net Total Receivables	0.309	2.97	8.62	10.6	13
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	10.5	19.2	41	51.7	67.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	43.6	71.7	83.4	89.4	84.9
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	54.9	92	126	142	155
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.48	6.83	11.9	21.2	27
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	16.5	27.9	58.9	61.8	66.8
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	38.4	64.1	66.7	79.7	88
Total Liabilities & Shareholders' Equity	54.9	92	126	142	155
Total Common Shares Outstanding